Literature DB >> 12183561

Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin.

M C Waghabi1, C M L M Coutinho, M N C Soeiro, M C S Pereira, J-J Feige, M Keramidas, A Cosson, P Minoprio, F Van Leuven, T C Araújo-Jorge.   

Abstract

Trypanosoma cruzi proteinases are involved in host cell invasion in human patients and in mouse models. In mice, murine alpha(2)-macroglobulin (MAM) and murinoglobulin are circulating plasma proteinase inhibitors that also have important roles in inflammation and immune modulation. To define their role in experimental Chagas disease, we investigated the susceptibility to T. cruzi infection of mice that are deficient only in alpha2-macroglobulins (AM-KO) or in both MAM and monomeric murinoglobulin-1 (MM-KO), relative to the wild type (WT). Despite the high parasite load, parasitemia was lower in AM-KO and MM-KO mice than in WT mice. Nevertheless, we observed a significantly higher parasite load in the hearts of AM-KO and MM-KO mice, i.e., more amastigote nests and inflammatory infiltrates than in WT mice. This result demonstrates a protective role for MAM in the acute phase of murine T. cruzi infection. We further demonstrated in vitro that human alpha2-macroglobulins altered the trypomastigote morphology and motility in a dose-dependent way, and that also impaired T. cruzi invasion in cardiomyocytes. Finally, we demonstrated that the levels of transforming growth factor beta in AM-KO mice increased significantly in the third week postinfection, concomitant with high amastigote burden and important fibrosis. Combined, these in vivo and in vitro findings demonstrate that the MAM contribute to the resistance of mice to acute myocarditis induced by experimental T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183561      PMCID: PMC128220          DOI: 10.1128/IAI.70.9.5115-5123.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation.

Authors:  C T Chu; S V Pizzo
Journal:  Lab Invest       Date:  1994-12       Impact factor: 5.662

2.  Heterogeneity in the plasma levels of two acute-phase proteins in mice from inbred strains infected with Trypanosoma cruzi.

Authors:  M R Luz; F van Leuven; T C Araújo-Jorge
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

3.  Alpha 2-macroglobulin in experimental and human Chagas' disease.

Authors:  T C Araújo-Jorge; M R Luz; C M Coutinho; N Medrano; M N Soeiro; M N Meirelles; L Isaac; F Van Leuven
Journal:  Ann N Y Acad Sci       Date:  1994-09-10       Impact factor: 5.691

Review 4.  The challenge of chagasic cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications.

Authors:  M A Rossi; R B Bestetti
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

5.  Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro.

Authors:  M N Meirelles; L Juliano; E Carmona; S G Silva; E M Costa; A C Murta; J Scharfstein
Journal:  Mol Biochem Parasitol       Date:  1992-06       Impact factor: 1.759

6.  Targeted inactivation of the mouse alpha 2-macroglobulin gene.

Authors:  L Umans; L Serneels; L Overbergh; K Lorent; F Van Leuven; H Van den Berghe
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

7.  Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.

Authors:  R M Gómez; C G Castagnino; M I Berría
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

Review 8.  Trypanosoma cruzi recognition by macrophages and muscle cells: perspectives after a 15-year study.

Authors:  T C De Araujo-Jorge; H S Barbosa; M N Meirelles
Journal:  Mem Inst Oswaldo Cruz       Date:  1992       Impact factor: 2.743

9.  Chagas' disease is attenuated in mice lacking gamma delta T cells.

Authors:  E C Santos Lima; P Minoprio
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway.

Authors:  M Ming; M E Ewen; M E Pereira
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

View more
  18 in total

1.  Specific antibodies induce apoptosis in Trypanosoma cruzi epimastigotes.

Authors:  Ana María Fernández-Presas; Patricia Tato; Ingeborg Becker; Sandra Solano; Natalia Copitin; Natalia Kopitin; Miriam Berzunza; Kaethe Willms; Joselin Hernández; José Luis Molinari
Journal:  Parasitol Res       Date:  2010-03-18       Impact factor: 2.289

2.  Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion.

Authors:  Mariana C Waghabi; Michelle Keramidas; Sabine Bailly; Wim Degrave; Leila Mendonça-Lima; Maria de Nazaré C Soeiro; Maria de Nazareth L Meirelles; Sidnei Paciornik; Tania C Araújo-Jorge; Jean-Jacques Feige
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

3.  Molecular dissection of the human alpha2-macroglobulin subunit reveals domains with antagonistic activities in cell signaling.

Authors:  Elisabetta Mantuano; Gatambwa Mukandala; Xiaoqing Li; W Marie Campana; Steven L Gonias
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

4.  Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.

Authors:  Mariana C Waghabi; Elen M de Souza; Gabriel M de Oliveira; Michelle Keramidas; Jean-Jacques Feige; Tania C Araújo-Jorge; Sabine Bailly
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

5.  SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion.

Authors:  Mariana C Waghabi; Michelle Keramidas; Claudia M Calvet; Marcos Meuser; Maria de Nazaré C Soeiro; Leila Mendonça-Lima; Tania C Araújo-Jorge; Jean-Jacques Feige; Sabine Bailly
Journal:  Antimicrob Agents Chemother       Date:  2007-05-25       Impact factor: 5.191

6.  A phosphoproteomic approach towards the understanding of the role of TGF-β in Trypanosoma cruzi biology.

Authors:  Patrícia M Ferrão; Fabiane L de Oliveira; Wim M Degrave; Tania C Araujo-Jorge; Leila Mendonça-Lima; Mariana C Waghabi
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

7.  Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease.

Authors:  Fabiane L de Oliveira; Tania C Araújo-Jorge; Elen M de Souza; Gabriel M de Oliveira; Wim M Degrave; Jean-Jacques Feige; Sabine Bailly; Mariana C Waghabi
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

8.  Together and apart: inhibition of DNA synthesis by connexin-43 and its relationship to transforming growth factor β.

Authors:  Maya M Jeyaraman; Robert R Fandrich; Elissavet Kardami
Journal:  Front Pharmacol       Date:  2013-07-19       Impact factor: 5.810

9.  Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection.

Authors:  Michael D Lewis; Amanda Fortes Francisco; Martin C Taylor; Hollie Burrell-Saward; Alex P McLatchie; Michael A Miles; John M Kelly
Journal:  Cell Microbiol       Date:  2014-05-01       Impact factor: 3.715

10.  The impact of surfactant protein-A on ozone-induced changes in the mouse bronchoalveolar lavage proteome.

Authors:  Rizwanul Haque; Todd M Umstead; Willard M Freeman; Joanna Floros; David S Phelps
Journal:  Proteome Sci       Date:  2009-03-26       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.